Endurance Wealth Management, Inc. / TMO
Endurance Wealth Management, Inc.’s Thermo Fisher Scientific Inc Position
Does Endurance Wealth Management, Inc. own Thermo Fisher Scientific Inc (TMO)? Yes — 49.4K shares worth $26M (+3.52% of its 13F portfolio) as of Q2 2023, down from 49.5K shares the prior filed quarter.
Position Value
$26M
Q2 2023
Shares
49.4K
% of Portfolio
+3.52%
Quarters Held
18
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 49.4K | $26M | +3.52% |
| Q1 2023 | 49.5K | $29M | +4.04% |
| Q4 2022 | 49.7K | $27M | +4.12% |
| Q3 2022 | 48.9K | $25M | +4.10% |
| Q2 2022 | 49.2K | $27M | +4.06% |
| Q1 2022 | 49.2K | $29M | +3.76% |
| Q4 2021 | 54.2K | $36M | +3.89% |
| Q3 2021 | 57.7K | $33M | +3.67% |
| Q2 2021 | 58.9K | $30M | +3.29% |
| Q1 2021 | 59.2K | $27M | +3.18% |
| Q4 2020 | 59.4K | $28M | +3.50% |
| Q3 2020 | 59.0K | $26M | +3.84% |
| Q2 2020 | 60.3K | $22M | +3.58% |
| Q1 2020 | 61.0K | $17M | +3.32% |
| Q4 2019 | 61.5K | $20M | +3.06% |
| Q3 2019 | 61.8K | $18M | +2.99% |
| Q2 2019 | 62.0K | $18M | +2.87% |
| Q1 2019 | 62.8K | $17M | +2.82% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurance Wealth Management, Inc.’s full portfolio or all institutional holders of TMO.